Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
BeiGene, Ltd. (BGNE)
Sector: Healthcare; Industry: Biotechnology

BeiGene, Ltd., a commercial-stage biotechnology company, develops and commercializes molecularly-targeted and immuno-oncology cancer therapeutics in the People's Republic of China, the United States, and internationally. The company's clinical stage drug candidates comprise Zanubrutinib, a BTK inhibitor to treat various lymphomas; Tislelizumab, an anti-PD-1 antibody to treat various solid and hematological cancers; Pamiparib, an inhibitor of PARP1 and PARP2 to treat various solid tumors; Lifirafenib and BGB-3245 to treat various malignancies, such as melanoma, NSCLC, and endometrial cancer; and Sitravatinib, a multi-kinase inhibitor to treat NSCLC, melanoma, and other solid tumor. BeiGene, Ltd. was founded in 2010 and is based in Beijing, the People's Republic of China.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-06-18 Wang Lai Global Head of R&D Sell 802 $331.15 $265,583 Yes
2021-06-18 Huang Jane CMO, Hematology Sell 469 $325.66 $152,733 Yes
2021-06-18 Liang Howard CFO & Chief Strategy Officer Sell 486 $325.89 $158,383 No
2021-06-07 Wu Xiaobin President, COO & GM China Sell 3,398 $352.54 $1,197,917 No
2021-06-07 Liang Howard CFO & Chief Strategy Officer Sell 650 $354.16 $230,203 No
2021-06-07 Wang Lai Global Head of R&D Sell 656 $354.26 $232,392 No
2021-06-07 Huang Jane CMO, Hematology Sell 603 $351.55 $211,986 No
2021-06-01 Huang Jane CMO, Hematology Sell 2,040 $357.98 $730,281 Yes
2021-05-10 Wang Xiaodong Chair, Scientific Advisory Brd Sell 3,394 $300.46 $1,019,752 Yes
2021-05-03 Wu Xiaobin President, COO & GM China Sell 6,715 $343.00 $2,303,245 No
2021-04-29 Huang Jane CMO, Hematology Sell 1,500 $354.92 $532,387 Yes
2021-03-29 Huang Jane CMO, Hematology Sell 1,500 $324.00 $485,993 Yes
2021-02-26 Huang Jane CMO, Hematology Sell 1,500 $320.73 $481,099 Yes
2021-01-29 Huang Jane CMO, Hematology Sell 1,500 $322.99 $484,492 Yes
2021-01-15 Liang Howard CFO & Chief Strategy Officer Sell 14,000 $344.85 $4,827,945 Yes
2021-01-04 BAKER BROS. ADVISORS LP 10%-Owner, Director Sell 121,154 $220.50 $26,714,457 No
2020-12-29 Huang Jane CMO, Hematology Sell 1,500 $249.13 $373,690 Yes
2020-12-14 Liang Howard CFO & Chief Strategy Officer Sell 91,900 $229.04 $21,048,454 Yes
2020-12-04 BAKER BROS. ADVISORS LP 10%-Owner, Director Sell 1,511,546 $220.50 $333,295,893 No
2020-11-30 Huang Jane CMO, Hematology Sell 1,500 $267.82 $401,723 Yes
2020-10-29 Huang Jane CMO, Hematology Sell 1,500 $300.06 $450,093 Yes
2020-10-16 Wang Xiaodong Chair, Scientific Advisory Brd Sell 5,000 $320.00 $1,600,000 No
2020-10-05 Wang Xiaodong Chair, Scientific Advisory Brd Sell 5,000 $300.00 $1,500,000 No
2020-10-05 Wu Xiaobin President & GM China Sell 4,000 $300.00 $1,200,000 No
2020-10-05 Liang Howard CFO & Chief Strategy Officer Sell 14,000 $299.60 $4,194,413 Yes
2020-09-29 Huang Jane CMO, Hematology Sell 1,500 $280.38 $420,568 Yes
2020-09-29 OYLER JOHN Chief Executive Officer Sell 54,303 $280.39 $15,226,093 No
2020-09-25 Wang Xiaodong Chair, Scientific Advisory Brd Sell 5,000 $280.42 $1,402,116 No
2020-09-25 Wu Xiaobin President & GM China Sell 4,000 $280.35 $1,121,406 No
2020-09-17 Wang Xiaodong Chair, Scientific Advisory Brd Sell 5,000 $260.27 $1,301,356 No

Insider Smart

Upwork Inc (UPWK) - GRETSCH GREGORY C. Director of Upwork, made a bulk buy of 500K shares right before the big gap up, which is also the largest buy of the past 12 months.